Kristin A. Connarn focuses her practice on life sciences patent prosecution and patent portfolio development and management in the fields of biotechnology and pharmaceuticals. Kristin advises clients on intellectual property (IP) issues, develops and delivers training sessions for employees and managers, and counsels in-house patent team members regarding invention disclosures. She has experience with preparing patentability, invalidity and non-infringement legal opinions, landscape and freedom to operate studies, due diligence, prior art searches and coordinating in-house patent committee meetings.

Show More


  • Responsible for the global patent portfolio management of Takeda’s inflammatory bowel disease biologic, Entyvio®
  • Provides strategic counseling to corporate clients of all sizes, from start-ups to multinational pharmaceutical companies, nonprofits, universities, and venture capital and private equity investors
  • Identified and evaluated third-party IP risks, to help clients achieve business objectives related to acquisition

Show More


  • The Best Lawyers in America 2018, Patent Law
  • Legal 500 US 2018
  • Intellectual Asset Management (IAM) Patent 1000 – The World’s Leading Patent Practitioners 2017

Show More


  • American Intellectual Property Law Association, co-chair of the Biosimilar Subcommittee Biological Product Development and Competition Subcommittee


Suffolk University Law School, JD, cum laude, 2005
Worcester Polytechnic Institute, BS, Biotechnology, with high distinction, 1999

New Hampshire

Courts / Agencies
US Patent and Trademark Office
US District Court for the District of Massachusetts